Uptake of the neurotoxin, 4-methylphenylpyridinium, into chromaffin granules and synaptic vesicles: a proton gradient drives its uptake through monoamine transporter.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Archives of Biochemistry and Biophysics

• Publication date

  1993-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/ABBI.1993.1422PMID 8373164
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.

  1992cited by this paper
• Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium.

  1992cited by this paper
• ATP-dependent uptake of 5-hydroxytryptamine by secretory granules isolated from thyroid parafollicular cells.

  1991cited by this paper
• Mechanism of Accumulation of the 1‐methyl‐4‐Phenylpyridinium Species into Mouse Brain Synaptosomes

  1991cited by this paper
• One-step purification of Escherichia coli H(+)-ATPase (F0F1) and its reconstitution into liposomes with neurotransmitter transporters.

  1991cited by this paper
• H(+)-ATPase, a primary pump for accumulation of neurotransmitters, is a major constituent of brain synaptic vesicles.

  1990cited by this paper
• Energy coupling of L-glutamate transport and vacuolar H(+)-ATPase in brain synaptic vesicles.

  1990cited by this paper
• Presence of 5-hydroxytryptamine (serotonin) transport coupled with vacuolar-type H(+)-ATPase in neurosecretory granules from bovine posterior pituitary.

  1990cited by this paper
• Cold inactivation of vacuolar proton-ATPases.

  1989cited by this paper
• Interaction of anions and ATP with the coated vesicle proton pump.

  1989cited by this paper
• Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport.

  1988cited by this paper
• Characteristics of the transport of the quaternary ammonium 1-methyl-4-phenylpyridinium by chromaffin granules.

  1988cited by this paper
• Energy-driven uptake of the neurotoxin 1-methyl-4-phenylpyridinium into chromaffin granules via the catecholamine transporter.

  1988cited by this paper
• Biochemical Events in the Development of Parkinsonism Induced by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine

  1987cited by this paper
• The purified ATPase from chromaffin granule membranes is an anion-dependent proton pump.

  1987cited by this paper
• Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells.

  1987cited by this paper
• Internal anion binding site and membrane potential dominate the regulation of proton pumping by the chromaffin granule ATPase.

  1987cited by this paper
• Mode of inhibition of sodium azide on H+‐ATPase of Escherichia coli

  1987cited by this paper
• Bioenergetics of secretory vesicles.

  1986cited by this paper
• Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.

  1986cited by this paper
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

  1985cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• Characterization of the monoamine carrier of chromaffin granule membrane by binding of [2-3H]dihydrotetrabenazine.

  1983cited by this paper
• Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Proton-translocating Mg2+-dependent ATPase activity in insulin-secretory granules.

  1982cited by this paper
• A potassium ion diffusion potential causes adrenaline uptake in chromaffin-granule 'ghosts'.

  1979cited by this paper
• Biological amine transport in chromaffin ghosts. Coupling to the transmembrane proton and potential gradients.

  1979cited by this paper
• Protonmotive force and catecholamine transport in isolated chromaffin granules.

  1979cited by this paper
• Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Ion permeability of isolated chromaffin granules

  1976cited by this paper
• A rapid, sensitive, and specific method for the determination of protein in dilute solution.

  1973cited by this paper
• The uptake of isoprenaline and noradrenaline by the perfused rat heart.

  1966cited by this paper

• Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action.

  2018cites this paper
• Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain

  2016cites this paper
• Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.

  2016cites this paper
• action illuminated through optical monitoring of synaptic vesicles in Drosophila brain.

  2016cites this paper
• Mild MPP+ exposure impairs autophagic degradation through a novel lysosomal acidity‐independent mechanism

  2016cites this paper
• The neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseases.

  2015cites this paper
• Changes in Neuronal Dopamine Homeostasis following 1-Methyl-4-phenylpyridinium (MPP+) Exposure*

  2015cites this paper
• MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modelling of Parkinson’s Disease

  2014cites this paper
• Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein.

  2013cites this paper
• Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity.

  2012cites this paper
• Nomifensine alters sex differences in striatal dopaminergic function

  2012cites this paper
• Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistry

  2011cites this paper
• Differences in reserpine-induced striatal dopamine output and content between female and male mice: implications for sex differences in vesicular monoamine transporter 2 function.

  2008cites this paper
• Our research on proton pumping ATPases over three decades: their biochemistry, molecular biology and cell biology

  2007cites this paper
• Sex Differences in K+‐Evoked Striatal Dopamine Output from Superfused Striatal Tissue Fragments of Reserpine‐Treated CD‐1 Mice

  2007cites this paper
• Vesicular monoamine transporter 2: Role as a novel target for drug development

  2006cites this paper
• Depletion and recovery of catecholamines in several organs of rats treated with reserpine.

  2006cites this paper
• Testosterone modulation of striatal dopamine output in orchidectomized mice

  2006cites this paper
• Methamphetamine-induced disruption of dopamine homeostasis : the ins and outs of transport

  2006cites this paper
• Sex differences in dopamine reuptake pathways of the nigrostriatal dopaminergic system in mice.

  2006cites this paper
• Dopamine transporter function differences between male and female CD-1 mice.

  2005cites this paper
• Defunctionalized lobeline analogues: structure-activity of novel ligands for the vesicular monoamine transporter.

  2005cites this paper
• Proton pumping ATPases and diverse inside-acidic compartments.

  2004cites this paper
• Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  2001cites this paper
• Norsalsolinol uptake into secretory vesicles via vesicular monoamine transporter and its secretion by membrane depolarization or purinoceptor stimulation in PC12 cells.

  2001influential citation
• In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.

  2000influential citation
• Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.

  2000cites this paper
• Luminal acidification of diverse organelles by V-ATPase in animal cells.

  2000cites this paper
• Dopamine transporters and neuronal injury.

  1999cites this paper
• The molecular basis for hepatobiliary transport of organic cations and organic anions.

  1999cites this paper
• Diverse roles of single membrane organelles: factors establishing the acid lumenal pH.

  1998cites this paper
• Analysis of neurotransmitter transport into secretory vesicles.

  1998cites this paper
• The neurotoxin 1-methyl-4-phenylpyridinium is a substrate for the canalicular organic cation/H+ exchanger.

  1997cites this paper
• The Neurotoxin 1-Methyl-4-phenylpyridinium Is a Substrate for the Canalicular Organic Cation / H 1 Exchanger 1

  1997cites this paper
• Chimeric Vesicular Monoamine Transporters Identify Structural Domains That Influence Substrate Affinity and Sensitivity to Tetrabenazine (*)

  1996cites this paper
• Membrane energization by proton pumps is important for compartmentalization of drugs and toxins: a new type of active transport.

  1996cites this paper
• Organic cation transport by rat liver lysosomes.

  1995cites this paper
• Identification of Residues Involved in Substrate Recognition by a Vesicular Monoamine Transporter (*)

  1995cites this paper
• ATP-dependent uptake of anti-neoplastic agents by acidic organelles.

  1994cites this paper